TherapeuticsMD Announces Participation in Upcoming Investor Conferences
TherapeuticsMD, Inc. (NASDAQ: TXMD) will participate in two upcoming investor conferences, showcasing its commitment to women’s healthcare. The first event is the Cowen Virtual Healthcare Conference on March 3, 2021, at 3:20 p.m. Eastern time. The second is the H.C. Wainwright Global Life Sciences Conference on March 9, 2021, with a presentation available at 11:00 a.m. Eastern time. Live webcasts can be accessed through the company’s website. TherapeuticsMD focuses on innovative products for women, addressing key health issues throughout their lives.
- None.
- None.
TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced that the company will participate at the following investor conferences:
Conference |
Cowen Virtual Healthcare Conference |
||
Date |
Wednesday, March 3, 2021 |
||
Time |
3:20 p.m. Eastern time |
Conference |
H.C. Wainwright Global Life Sciences Conference |
||
Date |
Tuesday, March 9, 2021 |
||
Time |
11:00 a.m. Eastern time the company presentation will be made available online as part of a virtual library. |
A live webcast of the Cowen presentation and replays of both presentations can be accessed on the company’s website, www.therapeuticsmd.com, on the Home Page or under the “Investors & Media” section.
About TherapeuticsMD
TherapeuticsMD, Inc. is an innovative, leading healthcare company, focused on developing and commercializing novel products exclusively for women. Our products are designed to address the unique changes and challenges women experience through the various stages of their lives with a therapeutic focus in family planning, reproductive health, and menopause management. The Company is committed to advancing the health of women and championing awareness of their healthcare issues. To learn more about TherapeuticsMD, please visit www.therapeuticsmd.com or follow us on Twitter: @TherapeuticsMD and on Facebook: TherapeuticsMD.
Forward-Looking Statements
This press release by TherapeuticsMD, Inc. may contain forward-looking statements. Forward-looking statements may include, but are not limited to, statements relating to TherapeuticsMD’s objectives, plans and strategies as well as statements, other than historical facts, that address activities, events or developments that the company intends, expects, projects, believes or anticipates will or may occur in the future. These statements are often characterized by terminology such as "believes," "hopes," "may," "anticipates," "should," "intends," "plans," "will," "expects," "estimates," "projects," "positioned," "strategy" and similar expressions and are based on assumptions and assessments made in light of management’s experience and perception of historical trends, current conditions, expected future developments and other factors believed to be appropriate. Forward-looking statements in this press release are made as of the date of this press release, and the company undertakes no duty to update or revise any such statements, whether as a result of new information, future events or otherwise. Forward-looking statements are not guarantees of future performance and are subject to risks and uncertainties, many of which are outside of the company’s control. Important factors that could cause actual results, developments and business decisions to differ materially from forward-looking statements are described in the sections titled "Risk Factors" in the company’s filings with the Securities and Exchange Commission, including its most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as well as reports on Form 8-K, and include the following: the effects of the COVID-19 pandemic; the company’
FAQ
What is the date and time for the TherapeuticsMD presentation at the Cowen Virtual Healthcare Conference?
When will the H.C. Wainwright Global Life Sciences Conference presentation be available?
Where can I watch the TherapeuticsMD conference presentations?
What is the focus of TherapeuticsMD, Inc.?